Bioequivalency Study of Famciclovir 500 mg Tablets Under Fasted Conditions

Completed · Not applicable

Conditions studied: Herpes

In brief

The objective of this study was to prove the bioequivalence of Famciclovir 500 mg Tablets under fasting conditions.

Key facts

Study ID

NCT01321515

Run by

Roxane Laboratories

People needed

36

Starts

2007-07-01

Expected to finish

2007-07-01

Last updated by the study team

2018-01-23

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening

You may not qualify if…

• Positive test for HIV, Hepatitis B, or Hepatitis C.
• Treatment with known enzyme altering drugs.
• History of allergic or adverse response to famciclovir, penciclovir or any comparable or similar product.

Where it is running

• Advanced Biomedical Research, Inc. — Hackensack, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.